These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5419089)

  • 1. [Hemodynamic, electrocardiographic, ergometric, mechanographic, radiological and psychological studies of the action of propranolol (Inderal) in the essential hyperkinetic syndrome].
    Krauss S; Dârlea G; Irimescu R; Edelhauser V
    Med Interna (Bucur); 1970 Apr; 22(4):437-44. PubMed ID: 5419089
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term propranolol therapy in essential circulatory hyperkinesis.
    Török E; Bajkay G; Gulyás A; Istvánffy M; Matos L
    Int J Clin Pharmacol; 1972 Nov; 6(4):364-74. PubMed ID: 4629827
    [No Abstract]   [Full Text] [Related]  

  • 3. [Regulation of the heart muscle contractility in essential circulatory hyperkinesis].
    Simonyi J
    Dtsch Gesundheitsw; 1969 Oct; 24(43):2036-8. PubMed ID: 5365550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary cardiac hyperkinetic syndrome: diagnosis and therapy].
    Bartorelli C; Guazzi M
    Riv Med Aeronaut Spaz; 1974; 37(3-4):261-79. PubMed ID: 4470230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of inderal on the coronary blood circulation].
    Kaverina NV; Kareva GF; Markova GA
    Farmakol Toksikol; 1968; 31(2):169-74. PubMed ID: 5674669
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the action of propranolol (inderal) on the contractile function of the heart].
    Balgma KA; Kont M
    Kardiologiia; 1969 May; 9(5):108-11. PubMed ID: 5805764
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dependence of the inhibitory effect of Inderal on the increase in heart rate].
    Walecka E; Kosowski Z; Romanowska-Górecka B
    Wiad Lek; 1971 Jul; 24(3):189-92. PubMed ID: 5548716
    [No Abstract]   [Full Text] [Related]  

  • 9. [The action of chloroquine on the myocardium. Hemodynamic and electrocardiographic study].
    Sfikakis P; Bakoulas G; Giamarellou H; Miniati C; Voridis E
    Therapeutique; 1971 Apr; 47(4):383-5. PubMed ID: 5564050
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of anaprilin on cardiac hemodynamic indices in elderly hypertensive patients].
    Severova NL
    Vrach Delo; 1983 May; (5):26-30. PubMed ID: 6136127
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of stress and hypoxic damage to the heart using the beta-blockader inderal].
    Ustinova EE
    Kardiologiia; 1983 Jul; 23(7):90-3. PubMed ID: 6620821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of propranolol on circulatory hemodynamics of patients with coronary heart failure in the light of polycardiographic examination.
    Mazurowa A; Tracz W
    Pol Med J; 1970; 9(4):827-34. PubMed ID: 5477489
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of acute myocardial infarctions with beta-receptor-blockers. II. Hemodynamic effects of propranolol with and without combination therapy with nitroglycerin (author's transl)].
    Lehmann HU; Oeff M; Witt E; Hochrein H
    Z Kardiol; 1981 Oct; 70(10):748-53. PubMed ID: 6795841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation by an alpha-adrenolytic agent, nicergoline, of the cardiac effects of propranolol.
    Boismare F; Moore N; Decourt S; Paux G; Saligaut C; Chretien P
    Methods Find Exp Clin Pharmacol; 1983; 5(2):83-8. PubMed ID: 6876944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic antagonism of propranolol in dogs. III. Effects of dopamine-isoproterenol and glucagon on hemodynamics and myocardial oxygen consumption in ischemic hearts during chronic propranolol administration.
    Wei J; Spotnitz HM; Spotnitz WD; Benvenisty AI; Haasler GB; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1984 May; 87(5):732-42. PubMed ID: 6717051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Inderal on certain hemodynamic indices in arterial hypertension].
    Kocemba J; Dubiel J; Gabryś B
    Pol Tyg Lek; 1970 Aug; 25(34):1280-2. PubMed ID: 5507157
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of inderal as an electrocardiographic functional test. Comparison of its value with raupasil and ergotamine tests].
    Lukasik S; Wrabec K; Wojewodzka M; Mazurek W
    Pol Tyg Lek; 1970 Nov; 25(45):1697-9. PubMed ID: 5488177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrocardiographic changes in the hyperkinetic cardiac syndrome].
    Müller S
    Z Gesamte Inn Med; 1972 Jul; 27(14):609-15. PubMed ID: 5082875
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the action of propranolol on the phases of cardiac dynamics in normal, myocardiosclerotic and hypersympathicotonic subjects].
    Lixi M; Camoglio E; Sassu P; Biddau C; Porrazzo G; Raffo M; Cherchi A
    Boll Soc Ital Cardiol; 1966; 11(4):1510-22. PubMed ID: 5992067
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronopharmacodynamics of betacap (long-acting propranolol) in patients with hypertension stage II].
    Zaslavskaia RM; Zhamankulov KA; Zhumabaeva TN; Teĭblium MM
    Klin Med (Mosk); 1998; 76(4):38-40. PubMed ID: 9613081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.